The aim of this observational program is to generate data on the use of Tredaptive (nicotinic acid/laropiprant) for lipid management under routine medical practice conditions.
Study Type
OBSERVATIONAL
Enrollment
2,390
Number of Participants With Lipid Panel Control
Lipid Panel Control was defined as achieving target for one or more of the following parameters: low-density lipoprotein cholesterol (LDL-C) at goal (\<100mg/dL), high-density lipoprotein cholesterol (HDL-C) within normal range (40mg/dL for males and 50mg/dL for females), and/or triglycerides within normal range (≤ 150mg/dL).
Time frame: From Visit 1 entrance evaluation (Week 0) to Visit 2 (between Weeks 8-22)
Number of Participants Who Reported Adverse Events
Time frame: Up to 22 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.